News – Page 6 – Department of Psychiatry & Behavioral Sciences

Sarah Kopelovich receives Beacon Award

Department News | May 28, 2026

Congratulations to Sarah Kopelovich, PhD, who received the Beacon Award at the 2026 Psychosis Care Virtual Conference.

Myra Parker receives Alumni of Impact Award

Department News | May 28, 2026

For her dedication to improving Indigenous public health, Myra Parker, JD, MPH, PhD was named the 2026 Alumni of Impact Awardee, the highest honor given to alumni from the UW School of Public Health.

Ask a Doctor: Ketamine

KUOW | May 27, 2026

Nathan Sackett, MD, MS joins KUOW to talk about ketamine, a substance that is showing up more and more in popular culture.

UW READU research team honored with Academy Health Mosaic Award

UW School of Public Health | May 26, 2026

Tessa Frohe, PhD and colleagues with READU are awarded the prestigious Mosaic Award, honoring their commitment to fostering diversity, equity, and community within health services and policy research.

UW CBHL named in honor of state legislature Frank Chopp

UW Magazine | May 12, 2026

Frank Chopp, who served as representative for Seattle’s 43rd Legislative District from 1995 to 2019, sponsored the bill that brought CBHL to life.

Myra Parker receives Alumni of Impact Award for commitment to Indigenous health

UW School of Public Health | May 12, 2026

For her dedication to improving Indigenous public health, Myra Parker, JD, MPH, PhD received the 2026 Alumni of Impact Award, the highest honor given to alumni from the UW School of Public Health.

Young people seeking non-alcoholic alternatives to drinking

KNKX | May 6, 2026

In 2021, about 51% of young adults reported drinking in the past month, and in 2024 it was down to 47.5%, says Mandy Owens, PhD.

Dror Ben-Zeev profiled by the NIH Fogarty International Center

Department News | April 30, 2026

Dror Ben-Zeev, PhD, director of the BRiTE Center, is profiled in the Fogarty International Center’s March/April edition of Global Health Matters about his work in West Africa to improve treatment and reduce symptom severity for people with serious mental illness.